According to our latest research, the global Juvenile Macular Degeneration Treatment market size reached USD 938.7 million in 2024, reflecting robust momentum driven by ongoing advancements in ophthalmic therapies and increasing awareness about inherited retinal diseases. The market is projected to expand at a CAGR of 7.9% from 2025 to 2033, with the total market value expected to attain USD 1,917.4 million by 2033. The primary growth factor fueling this expansion is the rapid evolution of gene and stem cell therapies, which are transforming the treatment landscape for rare and previously untreatable forms of juvenile macular degeneration.
https://growthmarketreports.co....m/report/juvenile-ma
إعجاب
علق
شارك
